Homocysteine as a Key Biomarker of Metabolic Stress During Foslevodopa/Foscarbidopa Infusion Therapy

Alkaline Phosphatases: A Potential Cause of Variability in Therapeutic Response to Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion?
Manon Auffret, Marc Vérin
Movement Disorders18 Jun 2026Peer-reviewedCC BY-NC-ND 4.0Full text2 citedNeurologyHAL
Ekbom Spectrum Psychosis Associated with 24-hour Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion in Parkinson’s Disease
Mario Meloni, Fabrizio De Ascaniis, Gianni Orofino +4
Clinical Psychopharmacology and Neuroscience30 Oct 2026Peer-reviewedCC BY-NC 4.0Full textNeurologyPMC
Continuous Subcutaneous Foslevodopa/Foscarbidopa Improves Nonmotor Symptoms and Fluctuations in Parkinson's Disease
Rosa De Micco, Oriana Ciaramaglia, Mattia Siciliano +4
European Journal of Neurology1 Oct 2026Peer-reviewedCC BY-NC 4.0Full textNeurologyPMCEurope PMC
Five Decades of Infusion Testing in Idiopathic Normal-Pressure Hydrocephalus: Resistance to CSF Outflow as a Biomarker in Search of a Gold Standard
Juan Sahuquillo, Murad Al-Nusaif, Monica Torrecilla-Vall-llossera +2
Biomedicines1 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Clinical Outcomes and Inflammatory Biomarker Changes After Intravenous Ketamine-Lidocaine Infusion in Refractory Neuropathic Pain: A Prospective Observational Pilot Study.
Ivan Keser, Slavenka Straus, Denis Imamovic +5
Cureus20 Sep 2026Peer-reviewedCC BYFull textPhysiologyEurope PMC

Cite

BibTeX

@article{magne2026homocysteine,
  title = {{Homocysteine as a Key Biomarker of Metabolic Stress During Foslevodopa/Foscarbidopa Infusion Therapy}},
  author = {Fabienne Ory Magne and Solène Frismand and Sophie Drapier and Guillaume Baille},
  journal = {Movement Disorders},
  year = {2026},
  month = oct,
  doi = {10.1002/mds.70539},
  url = {https://hal.science/hal-05788983v1},
}

RIS

TY  - JOUR
TI  - Homocysteine as a Key Biomarker of Metabolic Stress During Foslevodopa/Foscarbidopa Infusion Therapy
AU  - Fabienne Ory Magne
AU  - Solène Frismand
AU  - Sophie Drapier
AU  - Guillaume Baille
PY  - 2026
DA  - 2026/10/09
JO  - Movement Disorders
DO  - 10.1002/mds.70539
UR  - https://hal.science/hal-05788983v1
SN  - 0885-3185
SN  - 1531-8257
ER  -

Related

Cite